Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Asia
The High Court of Australia’s decision in Myriad has led some observers to hit the panic button and demand immediate legislative change, but only isolated naturally-occurring genes are affected and the ruling should be read in that light, says Grant Shoebridge of Shelston IP.   15 October 2015
Americas
Biotechnology company Enzo Biochem has settled a patent lawsuit after its rival Affymetrix agreed to pay $10 million to resolve the case.   14 October 2015
Americas
The double assessment of trademark applications for pharmaceutical products can cause problems for intellectual property owners, lawyers have claimed.   13 October 2015
Americas
Drug maker Mylan has been sued by pharmaceutical company Flamel Ireland for allegedly infringing a patent covering Coreg CR.   12 October 2015
Americas
Hedge fund manger Kyle Bass has secured his first inter partes review trial after the Patent Trial and Appeal Board instituted a challenge against a patent owned by biopharmaceutical company Shire.   9 October 2015
Americas
A US resident has been charged with trafficking counterfeit erectile dysfunction pills, the government has revealed.   8 October 2015
Big Pharma
The CJEU’s decision on how an SPC term is to be determined is likely to be welcomed by applicants and owners, but the court has left them to work out how to apply the ruling, say Natalia Wegner-Cribbs and Daniel Wise of Carpmaels & Ransford.   8 October 2015
Asia-Pacific
Australia’s highest court has said that naturally occurring nucleic acid molecules are not patentable, overturning a lower court ruling.   7 October 2015
Asia-Pacific
Australia’s government has said the period of data exclusivity available for biological drugs in the Trans-Pacific Partnership will be five years, despite pressure from the US to extend it to 12.   7 October 2015
Europe
The Court of Justice of the European Union (CJEU) has ended the uncertainty over the term of supplementary protection certificates (SPCs) by ruling that they begin once a party is notified of a marketing authorisation for a drug.   6 October 2015